No Carolina / NY / Florida
Ph: 561.316.3330

spot_img

Moleculin Announces Commencement of NIH-Funded Phase 2 Clinical Trial of STAT3 Inhibitor for the Treatment of Glioblastoma (NU 21C06)

Investigator-Initiated Phase 2 study is being conducted at Northwestern University in cooperation with Moleculin. Trial combines WP1066 and radiation, which demonstrated both significant therapeutic response and immune "memory" in glioblastoma animal models

Sample Post Title!

Sample Post Subtitle!

Morbi libero lectus, laoreet elementum viverra vitae, sodales sit amet nisi. Vivamus dolor ipsum, ultrices in accumsan nec, viverra in nulla.

Donec ligula sem, dignissim quis purus a, ultricies lacinia lectus. Aenean scelerisque, justo ac varius viverra, nisl arcu accumsan elit, quis laoreet metus ipsum vitae sem. Phasellus luctus imperdiet.

Donec tortor ipsum

Pharetra ac malesuada in, sagittis ac nibh. Praesent mattis ullamcorper metus, imperdiet convallis eros bibendum nec. Praesent justo quam, sodales eu dui vel, iaculis feugiat nunc.

Pellentesque faucibus orci at lorem viverra, id venenatis justo pretium. Nullam congue, arcu a molestie bibendum, sem orci lacinia dolor, ut congue dolor justo a odio.

Duis odio neque, congue ut iaculis nec, pretium vitae libero. Cras eros ipsum, eleifend rhoncus quam at, euismod sollicitudin erat.

Fusce imperdiet, neque ut sodales dignissim, nulla dui. Nam vel tortor orci.

Richtech Robotics Launches Elevator Enabled Robot, Reducing Pharmacist Burnout

With high operational accuracy, Medbot improves healthcare facility efficiency with a secure delivery, reducing operating costs and improving the overall patient experience. Medbot furthers Richtech Robotics’ mission of providing high-quality, stable robots to boost employee morale and improve customers’ bottom line.

1st International Harmony SHR® Robotic Rehabilitation System Installed at Prestigious Chinese University of Hong Kong Medical Centre

"This is a major milestone for our company as we work to expand our footprint and bring Harmony SHR to more providers and patients," said Harmonic Bionics CEO Mark Hunter. "There is tremendous opportunity for growth in Asia and this installation at CUHK Medical Centre is a great starting point to our intended success in the market."

Aerobiotix Supports Updates to AORN’s Sterile Technique Guidelines

Aerobiotix is committed to helping healthcare facilities meet these new guidelines: "The latest recommendations from AORN reinforce the essential role of advanced air decontamination systems in today's operating rooms. Aerobiotix is dedicated to providing technologies like the Illuvia Sense, which meet and exceed these new standards, ensuring safer surgical environments for patients and healthcare professionals
Post author namePost author url
Post author biographical information.

By using this website you agree to accept Medical Device News Magazine Privacy Policy